| 201 |
24518515 | EP2 signaling mediates suppressive effects of celecoxib on androgen receptor expression and cell proliferation in prostate cancer. | 2014 Mar |
2 |
| 202 |
24637636 | COX-2-independent effects of celecoxib sensitize lymphoma B cells to TRAIL-mediated apoptosis. | 2014 May 15 |
3 |
| 203 |
24640603 | Cyclooxygenase-2 inhibitor celecoxib suppresses invasion and migration of nasopharyngeal carcinoma cell lines through a decrease in matrix metalloproteinase-2 and -9 activity. | 2014 Feb |
1 |
| 204 |
24721459 | Celecoxib exerts protective effects on extracellular matrix metabolism of mandibular condylar chondrocytes under excessive mechanical stress. | 2014 Jun |
2 |
| 205 |
24794773 | Synthesis of N-benzenesulfonamide-1H-pyrazoles bearing arylsulfonyl moiety: novel celecoxib analogs as potent anti-inflammatory agents. | 2014 Jun 10 |
1 |
| 206 |
24802614 | COX-2 inhibitors arrest prostate cancer cell cycle progression by down-regulation of kinetochore/centromere proteins. | 2014 Jul |
2 |
| 207 |
24854838 | Celecoxib enhances radiosensitivity via induction of G₂-M phase arrest and apoptosis in nasopharyngeal carcinoma. | 2014 |
4 |
| 208 |
24859418 | COX2 expression in neuroblastoma increases tumorigenicity but does not affect cell death in response to the COX2 inhibitor celecoxib. | 2014 Aug |
1 |
| 209 |
24867695 | Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation. | 2014 Jul 8 |
1 |
| 210 |
24874483 | COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment. | 2014 Jul 8 |
2 |
| 211 |
24934992 | Novel pyrazoline derivatives as bi-inhibitor of COX-2 and B-Raf in treating cervical carcinoma. | 2014 Aug 1 |
1 |
| 212 |
24959102 | The ATRA-induced differentiation of medulloblastoma cells is enhanced with LOX/COX inhibitors: an analysis of gene expression. | 2014 |
2 |
| 213 |
24964373 | A role for prostaglandins in rapid cycling suggested by episode-specific gene expression shifts in peripheral blood mononuclear cells: a preliminary report. | 2014 Dec |
1 |
| 214 |
24989281 | [Effect of COX-2 inhibitor celecoxib on proliferation, apoptosis of HL-60 cells and its mechanism]. | 2014 Jun |
4 |
| 215 |
25006185 | Nonsteroidal anti-inflammatory drugs and cardiovascular outcomes in women: results from the women's health initiative. | 2014 Jul |
1 |
| 216 |
25066075 | New celecoxib multiparticulate systems to improve glioblastoma treatment. | 2014 Oct 1 |
2 |
| 217 |
25107843 | The PI3K/Akt pathway in colitis associated colon cancer and its chemoprevention with celecoxib, a Cox-2 selective inhibitor. | 2014 Jul |
1 |
| 218 |
25202054 | LLW-3-6 and celecoxib impacts growth in prostate cancer cells and subcellular localization of COX-2. | 2014 Sep |
1 |
| 219 |
25209136 | Prevention and Treatment of NSAID Gastropathy. | 2014 Dec |
1 |
| 220 |
25258584 | Effect of celecoxib on inhibiting tumor repopulation during radiotherapy in human FaDu squamous cell carcinoma. | 2014 |
1 |
| 221 |
25299780 | c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells. | 2014 Oct 9 |
3 |
| 222 |
25333664 | Effusanin E suppresses nasopharyngeal carcinoma cell growth by inhibiting NF-κB and COX-2 signaling. | 2014 |
2 |
| 223 |
25559449 | Ultrahigh-performance liquid chromatography/tandem mass spectrometry method for evaluating enzyme activity and screening inhibitors of cyclooxygenase-2. | 2014 Aug 30 |
1 |
| 224 |
25587329 | Celecoxib Up Regulates the Expression of Drug Efflux Transporter ABCG2 in Breast Cancer Cell Lines. | 2014 Fall |
3 |
| 225 |
23001685 | Celecoxib does not affect the release of hyaluronic acid in end stage osteoarthritic joints. | 2013 Sep |
1 |
| 226 |
23010081 | Celecoxib induces proliferation and Amphiregulin production in colon subepithelial myofibroblasts, activating erk1-2 signaling in synergy with EGFR. | 2013 Jan 1 |
1 |
| 227 |
23031659 | Are drug provocation tests still necessary to test the safety of COX-2 inhibitors in patients with cross-reactive NSAID hypersensitivity? | 2013 May-Jun |
1 |
| 228 |
23067366 | Long-term celecoxib can prevent the progression of persistent gastric intestinal metaplasia After H. pylori eradication. | 2013 Apr |
2 |
| 229 |
23167625 | Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53. | 2013 Jan |
3 |
| 230 |
23245395 | Celecoxib downregulates CD133 expression through inhibition of the Wnt signaling pathway in colon cancer cells. | 2013 Feb |
1 |
| 231 |
23268707 | Different cell cycle modulation by celecoxib at different concentrations. | 2013 Mar |
1 |
| 232 |
23307337 | Taurine enhances antinociception produced by a COX-2 inhibitor in an inflammatory pain model. | 2013 Jun |
1 |
| 233 |
23331485 | The anti-inflammatory effect of cyclooxygenase inhibitors in fibroblast-like synoviocytes from the human temporomandibular joint results from the suppression of PGE2 production. | 2013 Jul |
1 |
| 234 |
23358696 | The role of potassium channel activation in celecoxib-induced analgesic action. | 2013 |
5 |
| 235 |
23402310 | Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line. | 2013 Feb 12 |
1 |
| 236 |
23454135 | Antiproliferative effect of two novel COX-2 inhibitors on human keratinocytes. | 2013 May 13 |
1 |
| 237 |
23565678 | Developments in synthesis of the anti-inflammatory drug, celecoxib: a review. | 2013 May |
1 |
| 238 |
23670888 | Synthesis and biological evaluation of 4-arylphthalazones bearing benzenesulfonamide as anti-inflammatory and anti-cancer agents. | 2013 Jun |
1 |
| 239 |
23682075 | Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers. | 2013 Jul |
2 |
| 240 |
23706161 | OSU-03012 sensitizes breast cancers to lapatinib-induced cell killing: a role for Nck1 but not Nck2. | 2013 May 24 |
1 |
| 241 |
23731702 | Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling. | 2013 Jun 3 |
2 |
| 242 |
23737956 | Ursolic acid simultaneously targets multiple signaling pathways to suppress proliferation and induce apoptosis in colon cancer cells. | 2013 |
1 |
| 243 |
23778325 | Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX2 inhibitor (celecoxib) trial: results from a pilot study. | 2013 Aug |
1 |
| 244 |
23817417 | Synovial fibroblasts directly induce Th17 pathogenicity via the cyclooxygenase/prostaglandin E2 pathway, independent of IL-23. | 2013 Aug 1 |
1 |
| 245 |
23899748 | Aldosterone glucuronidation inhibition as a potential mechanism for arterial dysfunction associated with chronic celecoxib and diclofenac use in patients with rheumatoid arthritis. | 2013 Sep-Oct |
1 |
| 246 |
24156425 | [COX-2 inhibitor celecoxib can suppress the proliferation of FLT3-ITD positive acute myeloid leukemia cells with prominent down regulation of MEK/MCL-1 expression in vitro]. | 2013 Oct |
1 |
| 247 |
24211633 | Synthesis of novel 1,2,3-triazole based benzoxazolinones: their TNF-α based molecular docking with in-vivo anti-inflammatory, antinociceptive activities and ulcerogenic risk evaluation. | 2013 |
1 |
| 248 |
24520457 | Low doses of celecoxib stimulate human endometrium growth in a three-dimensional culture model. | 2013 Apr |
1 |
| 249 |
24570829 | Synthesis, Anti-Inflammatory and Anti- Nociceptive Activities and Cytotoxic Effect of Novel Thiazolidin-4-ones Derivatives as Selective Cyclooxygenase (COX-2) Inhibitors. | 2013 Dec |
1 |
| 250 |
21699540 | The cyclooxygenase-2 pathway via the PGE₂ EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone-induced demyelination. | 2012 May |
1 |